Vimarsana
Biggest News Aggregation in the World

Page 8 - Global External News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global External Today - Breaking & Trending Today

INVENTIVA: Inventiva reports its 2022 full-year results - Vimarsana News

INVENTIVA: Inventiva reports its 2022 full-year results

Cash and cash equivalents at €86.7 million and short term deposits at €1 million as of December 31, 2022 compared to €86.6 million and €8.8 million, respectively as of December 31, 2021 Inventiva

Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results - Vimarsana News

Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results

Daix , Long Island City , March 23, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with... | March 23, 2023

INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results - Vimarsana News

INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results

Daix (France), Long Island City (New York, United States), March 23, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results - Vimarsana News

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results

Investegate announcements from INVENTIVA, Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results

INVENTIVA: Correction: Inventiva reports preliminary financial results for Full-Year 2022¹ - Vimarsana News

INVENTIVA: Correction: Inventiva reports preliminary financial results for Full-Year 2022¹

Daix (France), Long Island City (New York, United States), February 14, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development